Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ SLC35D2 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA572720
Description
SLC35D2 Polyclonal Antibody for Western Blot, ICC/IF, ELISA
Antiporter transporting nucleotide sugars such as UDP-N-acetylglucosamine (UDP-GlcNAc), UDP-glucose (UDP-Glc) and GDP-mannose (GDP-Man) pooled in the cytosol into the lumen of the Golgi in exchange for the corresponding nucleosides monophosphates (UMP for UDP-sugars and GMP for GDP-sugars). May take part in heparan sulfate synthesis by supplying UDP-Glc-NAc, the donor substrate, and thus be involved in growth factor signaling.
Specifications
SLC35D2 | |
Polyclonal | |
Unconjugated | |
SLC35D2 | |
5730408I21Rik; fringe connection; hfrc; HFRC1; Homolog of Fringe connection protein 1; mUGTrel8; SLC35D2; solute carrier family 35 (UDP-GlcNAc/UDP-glucose transporter), member D2; solute carrier family 35 member D2; solute carrier family 35, member D2; SQV7L; SQV7-like protein; UDP-galactose transporter-related protein 8; UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter; UDP-N-acetylglucosamine transporter; UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter; UGTrel8 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
11046 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
ELISA, Western Blot, Immunocytochemistry | |
1 mg/mL | |
PBS with 0.02% sodium azide | |
Q76EJ3 | |
SLC35D2 | |
SLC35D2 antibody for a 14 amino acid synthetic peptide near the carboxy terminus of human SLC35D2. The immunogen is within the last 50 amino acids of SLC35D2. | |
100 μg | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction